AlphaGen withdraws shareholder vote on Quantum Vision deal from June 19 meeting

  • Alphagen Intelligence withdrew the shareholder vote on its March 31, 2026 share purchase agreement for the Quantum Vision transaction from the June 19 meeting.
  • The transaction approval resolution in the May 8 management circular, filed May 25 on SEDAR+, will not be considered.
  • Work continues with advisers, the CSE, and regulators on required disclosure, including a listing statement.
  • An amending agreement dated June 15 moved the outside date to seek CSE-required shareholder approval to Sept. 30, 2026 from April 30.
  • Any required shareholder vote on the transaction will be held at a later date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphagen Intelligence Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606151700PRIMZONEFULLFEED9747319) on June 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.